Centene

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Centene 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CNC

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. 

CEO
Sarah McGinty London
CEOSarah McGinty London
Employees
60,500
Employees60,500
Headquarters
St. Louis, Missouri
HeadquartersSt. Louis, Missouri
Founded
1984
Founded1984
Employees
60,500
Employees60,500

CNC Key Statistics

Market cap
23.07B
Market cap23.07B
Price-Earnings ratio
-4.34
Price-Earnings ratio-4.34
Dividend yield
Dividend yield
Average volume
5.63M
Average volume5.63M
High today
$47.49
High today$47.49
Low today
$46.07
Low today$46.07
Open price
$46.22
Open price$46.22
Volume
9.59M
Volume9.59M
52 Week high
$66.81
52 Week high$66.81
52 Week low
$25.08
52 Week low$25.08

Stock Snapshot

As of today, Centene(CNC) shares are valued at $47.25. The company's market cap stands at 23.07B, with a P/E ratio of -4.34.

As of 2026-01-08, Centene(CNC) stock has fluctuated between $46.07 and $47.49. The current price stands at $47.25, placing the stock +2.6% above today's low and -0.5% off the high.

The Centene(CNC)'s current trading volume is 9.59M, compared to an average daily volume of 5.63M.

During the past year, Centene(CNC) stock moved between $25.08 at its lowest and $66.81 at its peak.

During the past year, Centene(CNC) stock moved between $25.08 at its lowest and $66.81 at its peak.

CNC News

Sherwood News 11h
Insurers rise as House tees up ACA extension vote

Insurers rise as House tees up ACA extension vote Several health insurers rallied on Thursday as the House of Representatives is expected to pass a measure ext...

Insurers rise as House tees up ACA extension vote
Simply Wall St 17h
Can Barclays’ ACA Margin Upgrade Reframe Centene’s Core Government Health Strategy Narrative?

Recently, Barclays upgraded Centene’s rating after reviewing its positioning in the Affordable Care Act marketplace, highlighting the company’s ability to impro...

Can Barclays’ ACA Margin Upgrade Reframe Centene’s Core Government Health Strategy Narrative?
Simply Wall St 2d
A Look At Centene Valuation After Barclays Upgrade And Renewed Affordable Care Act Optimism

Barclays’ recent upgrade of Centene (CNC) to Overweight, supported by a detailed view of its Affordable Care Act business and margin potential, has pushed the s...

A Look At Centene Valuation After Barclays Upgrade And Renewed Affordable Care Act Optimism

Analyst ratings

65%

of 23 ratings
Buy
26.1%
Hold
65.2%
Sell
8.7%

More CNC News

Nasdaq 3d
Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and ma...

Why Investors Need to Take Advantage of These 2 Medical Stocks Now
TipRanks 3d
Centene price target raised to $59 from $45 at Bernstein

Bernstein analyst Lance Wilkes raised the firm’s price target on Centene (CNC) to $59 from $45 and keeps an Outperform rating on the shares. The firm sees a sec...

TipRanks 4d
Centene upgraded to Overweight from Equal Weight at Barclays

Barclays upgraded Centene (CNC) to Overweight from Equal Weight with a price target of $54, up from $44. The firm cites the company’s “attractive” Affordable Ca...

People also own

Based on the portfolios of people who own CNC. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.